Abstract

Vaccination against meningococcal ACWY has been part of the basic vaccination schedule for children and adolescents since 2019.
For certain risk groups, the SHC recommends the meningococcal group B vaccine, with booster doses for both vaccines depending on the group.
 
This new advice provides an overview of the vaccination schedules and a definition of the risk groups, namely:

  • persons at medical risk (see p. 4),
  • travellers to endemic areas or pilgrims of the Hadj/Umrah, and
  • laboratory staff in contact with invasive meningococci (new).
  • Recommendation
  • Europe
  • Belgium
  • Meningococcal disease